PubRank
Search
About
Pilar Delgado
Author PubWeight™ 59.18
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
Stroke
2005
2.24
2
Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.
Stroke
2006
2.20
3
Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes.
Stroke
2007
2.03
4
T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis.
Immunity
2011
2.00
5
Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions.
Stroke
2004
1.91
6
Microbleeds versus macrobleeds: evidence for distinct entities.
Stroke
2009
1.83
7
Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.
Stroke
2004
1.81
8
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Stroke
2008
1.54
9
Is it time to reassess the SITS-MOST criteria for thrombolysis?: A comparison of patients with and without SITS-MOST exclusion criteria.
Stroke
2009
1.51
10
The Rho exchange factors Vav2 and Vav3 favor skin tumor initiation and promotion by engaging extracellular signaling loops.
PLoS Biol
2013
1.50
11
[In-hospital ischemic strokes in patients admitted to Cardiology and Cardiac Surgery departments. Multi-centre registry].
Med Clin (Barc)
2011
1.45
12
IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.
Stroke
2012
1.45
13
Initiation of TCR signaling: regulation within CD3 dimers.
Immunol Rev
2003
1.20
14
Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques.
Stroke
2006
1.17
15
Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
Stroke
2005
1.16
16
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Stroke
2005
1.08
17
Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Stroke
2005
1.08
18
Determinants of white matter hyperintensity volume in patients with acute ischemic stroke.
J Stroke Cerebrovasc Dis
2010
1.07
19
Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke.
Stroke
2007
1.05
20
Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage.
Stroke
2013
1.02
21
Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction.
J Neurol
2009
1.02
22
Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis.
World J Gastroenterol
2010
0.99
23
Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator.
Stroke
2007
0.96
24
Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage.
Stroke
2012
0.96
25
Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis.
Stroke
2008
0.96
26
Role of chimaerins, a group of Rac-specific GTPase activating proteins, in T-cell receptor signaling.
Cell Signal
2007
0.93
27
ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy.
Neurobiol Aging
2010
0.91
28
Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhage.
PLoS One
2011
0.91
29
Oxidative stress after thrombolysis-induced reperfusion in human stroke.
Stroke
2010
0.91
30
MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.
Brain Pathol
2011
0.91
31
Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
J Cereb Blood Flow Metab
2007
0.88
32
Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis?
Ultrasound Med Biol
2008
0.88
33
Transcranial duplex sonography for monitoring hyperacute intracerebral hemorrhage.
Stroke
2009
0.84
34
Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke.
Neurodegener Dis
2012
0.84
35
A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.
Ann Neurol
2012
0.83
36
UNG shapes the specificity of AID-induced somatic hypermutation.
J Exp Med
2012
0.83
37
VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Cerebrovasc Dis
2011
0.83
38
Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.
J Proteomics
2012
0.82
39
Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful?
J Neurosurg
2010
0.82
40
Blood biomarkers in cardioembolic stroke.
Curr Cardiol Rev
2010
0.81
41
KCNK17 genetic variants in ischemic stroke.
Atherosclerosis
2009
0.81
42
Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease.
Atherosclerosis
2011
0.81
43
Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
J Neurosci Res
2009
0.81
44
Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.
Stroke
2012
0.81
45
Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients.
Eur Neurol
2011
0.79
46
Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design.
BMC Neurol
2013
0.79
47
Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis.
Diagn Microbiol Infect Dis
2012
0.78
48
Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
Cerebrovasc Dis
2009
0.77
49
ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke.
Neurosci Lett
2006
0.77
50
Genes involved in hemorrhagic transformations that follow recombinant t-PA treatment in stroke patients.
Pharmacogenomics
2013
0.77
51
[Usefulness of urgent combined carotid/transcranial ultrasound testing in early prognosis of TIA patients].
Med Clin (Barc)
2006
0.77
52
CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses.
World J Gastrointest Oncol
2013
0.76
53
Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.
Thromb Haemost
2009
0.76
54
Letter by Riba-Llena et al regarding article, "Not listened or not reported rather than silent stroke".
Stroke
2013
0.75
55
High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals.
J Cereb Blood Flow Metab
2016
0.75
56
Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke.
Thromb Haemost
2016
0.75
57
Presurgical evaluation in refractory epilepsy secondary to meningitis or encephalitis: bilateral memory deficits often preclude surgery.
Epileptic Disord
2007
0.75
58
Microalbuminuria and the Combination of MRI Markers of Cerebral Small Vessel Disease.
Cerebrovasc Dis
2016
0.75
59
Choroiditis as systemic manifestation of a Sweet's syndrome associated to myelodysplasia: a case report.
Haematologica
2002
0.75
60
Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia.
J Atheroscler Thromb
2015
0.75
61
[Detection of Chlamydia pneumoniae in human aortic tissue: kdtA gene amplification and in vitro hybridization].
Biomedica
2005
0.75